Ignite Creation Date:
2024-05-06 @ 1:19 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01776151
Status:
COMPLETED
Last Update Posted:
2023-03-21
First Post:
2012-09-18
Brief Title:
Arterial Elasticity A Substudy of Strategic Timing of AntiRetroviral Treatment START
Sponsor:
University of Minnesota
Organization:
University of Minnesota
Study Overview
Official Title:
Arterial Elasticity A Substudy of Strategic Timing of AntiRetroviral Treatment START
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out if starting anti-retroviral therapy ART above 500 cluster-of-differentiation-4 CD4 cellsmilliliter mL early ART group is better at reducing the stiffness of arteries than waiting to start ART until the CD4 drops below 350 cellsmL deferred ART group Artery stiffness has been associated with an increased risk of cardiovascular heart disease and could be useful as an earlier indicator of heart disease In this study the stiffness of arteries will be measured at study entry months 4 8 12 and annually thereafter using a tonometer on the participants forearm
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None